NCT00561418
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Hodgkin Disease, +22 more
- Locations
-
- Ohio State University Medical Center Columbus, Ohio, United States
Clinical trial condition
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
Explore clinical trials studying Precursor T-Cell Lymphoblastic Leukemia-Lymphoma. Study availability and eligibility vary by location and protocol.
297 public trials
56 recruiting studies
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma trial results
NCT00608361
- Conditions
- Adenocarcinoma, Adult Acute Lymphoblastic Leukemia in Remission, Adult B Acute Lymphoblastic Leukemia, +144 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- Los Angeles County-USC Medical Center Los Angeles, California, United States
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
NCT00045500
- Conditions
- Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +40 more
- Locations
-
- Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States
- NCI - Center for Cancer Research Bethesda, Maryland, United States
- Frederick Cancer Research and Development Center Frederick, Maryland, United States
Completed
LMB-2 Immunotoxin in Treating Young Patients With Relapsed or Refractory Leukemia or Lymphoma
NCT00085150
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Dendritic Cell Sarcoma, Interdigitating, +31 more
- Locations
-
- Winship Cancer Institute of Emory University Atlanta, Georgia, United States
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
- Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States
- Doernbecher Children's Hospital at Oregon Health & Science University Portland, Oregon, United States
Completed
Bryostatin 1 and Interleukin-2 in Treating Patients With Refractory Solid Tumors or Lymphoma
NCT00003993
- Conditions
- Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +43 more
- Locations
-
- National Institute on Aging - Baltimore Baltimore, Maryland, United States
NCT00002765
- Conditions
- Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +47 more
- Locations
-
- Laboratory of Molecular Biology Bethesda, Maryland, United States
- Medicine Branch Bethesda, Maryland, United States
NCT00019344
- Conditions
- Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +52 more
- Locations
-
- Medicine Branch Bethesda, Maryland, United States
Completed
S0355 Ixabepilone in Treating Patients With Advanced Solid Tumors or Lymphomas and Liver Dysfunction
NCT00049400
- Conditions
- Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +41 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States
- University of California Davis Cancer Center Sacramento, California, United States
- Cardinal Bernardin Cancer Center at Loyola University Medical Center Maywood, Illinois, United States
NCT00866671
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
- Locations
-
- GSK Investigational Site Aahur N, Denmark
- GSK Investigational Site Aalborg, Denmark
- GSK Investigational Site Koebenhavn Oe, Denmark
- GSK Investigational Site Odense C, Denmark
NCT01158274
- Conditions
- AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma, AIDS-related Diffuse Small Cleaved Cell Lymphoma, +151 more
- Locations
-
- University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States
- University Health Network-Princess Margaret Hospital Toronto, Ontario, Canada